In connection with this, a study in a murine model of CLL showed that heterozygous Sf3b1 mutation and Atm defects (11q deletion and/or mutation) together can generate clonal expansions of mature B cells consistent with clinical pathologic features of CLL [51]. This evidence concerns the gene ATM and B-cell chronic lymphocytic leukemia.